Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker?

Rabia Sari (istanbul, Turkey), Rabia Sari, Mustafa Ay, Emin Çelik, Ülgen Yalaz Tekan, Fulya Çiyiltepe, Feyza Kargin, Cuneyt Salturk, Özlem Mocin, Gokay Gungor, Nalan Adiguzel, Zuhal Karakurt

Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Session: Infections, sepsis, and pulmonary embolism
Session type: Poster Discussion
Number: 355
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rabia Sari (istanbul, Turkey), Rabia Sari, Mustafa Ay, Emin Çelik, Ülgen Yalaz Tekan, Fulya Çiyiltepe, Feyza Kargin, Cuneyt Salturk, Özlem Mocin, Gokay Gungor, Nalan Adiguzel, Zuhal Karakurt. Pulmonary originated sepsis: Can N/L ratio be used as follow-up marker?. Eur Respir J 2016; 48: Suppl. 60, 355

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction in pulmonary embolism: Neutrophil-lymphocyte and platelet-lymphocyte ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


C-reactive protein and pulmonary tuberculosis: What correlation with disease severity
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016

The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013

Electrocardiographic abnormalities in patients with low or moderate risk pulmonary embolism: Prevalence and association with PO2 /FiO2 ratio
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Asthma and the risk of pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF)
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021


Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015

The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Could uric acid be a marker of poor prognosis for pulmonary embolism?
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016